Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Oct;64(2):265-72.
doi: 10.1111/j.1476-5381.1978.tb17299.x.

Cardiovascular effects of acebutolol following coronary artery occlusion and reperfusion in anaesthetized dog

Cardiovascular effects of acebutolol following coronary artery occlusion and reperfusion in anaesthetized dog

W Chernecki et al. Br J Pharmacol. 1978 Oct.

Abstract

1 The effects of 5 mg/kg acebutolol given intravenously were investigated in anaesthetized dogs after (a) ligation of the left anterior descending coronary artery and (b) coronary reperfusion following 60 min of ligation of the anterior descending coronary artery. 2 Coronary artery ligation produced, after 4 to 6 h, persistent multiple ventricular ectopic beats and abnormalities of R and T waves and of the S-T segment. Administration of acebutolol, after the development of persistent ventricular arrhythmias, restored normal sinus rhythm within 5 min of injection. Electrocardiographic abnormalities were also reduced. 3 Coronary artery reperfusion (following 60 min of ligation) resulted in multiple ventricular ectopic beats, ventricular tachycardia and/or ventricular fibrillation. Pretreatment with acebutolol, 15 min before starting reperfusion, markedly reduced the arrhythmias. 4 Acebutolol did not affect peak inspiratory airway pressure. 5 Acebutolol produced significant bradycardia and slight, transient, hypotension. It was without effect on left ventricular systolic pressure, left ventricular end-diastolic pressure, cardiac output or pulmonary arterial pressure. 6 These results suggest beneficial effects of acebutolol in myocardial ischaemia and coronary reperfusion, without any significant risk of cardiodepression or bronchospasm.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lab Invest. 1964 Dec;13:1491-503 - PubMed
    1. Prog Cardiovasc Dis. 1971 Jan;13(4):374-91 - PubMed
    1. Biochem Pharmacol. 1977 Nov 1;26(21):2055-60 - PubMed
    1. Am J Cardiol. 1976 Nov 23;38(6):689-95 - PubMed
    1. Eur J Clin Pharmacol. 1975;8(1):11-4 - PubMed

LinkOut - more resources